The 100,000 Genomes Club
10 Countries Meet the Mark for National Genome Projects
10 Takeover Targets to Watch This Fall
Pace of Biopharma M&A Slows from First Half Stampede of Deals
Vertex’s David Altshuler Humanizes Drug Discovery
Lessons from Vertex’s Small Molecule Drug Development Program for Cystic Fibrosis
Scaling Up Cell Therapy Manufacturing
Moving Forward with an Early-on Strategy
For full access to this article login to GEN Select now.
Hope Springs Pluripotent—within Bounds
Therapeutics Based on Induced Pluripotent Stem Cells Are Nearing Clinical Trials
- For those who advocate therapeutic applications of induced pluripotent stem cells (iPSCs), these are heady times. New funding flows are opening, regulations are undergoing some “streamlining,” and clinical trials are being planned. Taken together, these developments justify optimism. Might they even inspire giddiness? Apparently not, if we may ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.